What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least four kinds of treatment regimens that have not worked or have stopped working. ABECMA is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your multiple myeloma cells.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
Learn about some factors you and your doctor should consider when determining if ABECMA is right for you.
Not an actual patient.
See results from a clinical trial of adults with relapsed or refractory MM.
Not an actual patient.
Resources designed to support you and your caregiver throughout the treatment journey.
Not an actual patient.